998 related articles for article (PubMed ID: 14770190)
1. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
[TBL] [Abstract][Full Text] [Related]
2. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG
Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481
[TBL] [Abstract][Full Text] [Related]
3. Responses to the cannabinoid receptor-1 antagonist, AM251, are more robust with age and with high-fat feeding.
Judge MK; Zhang Y; Scarpace PJ
J Endocrinol; 2009 Nov; 203(2):281-90. PubMed ID: 19679649
[TBL] [Abstract][Full Text] [Related]
4. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.
Crespillo A; Suárez J; Bermúdez-Silva FJ; Rivera P; Vida M; Alonso M; Palomino A; Lucena MA; Serrano A; Pérez-Martín M; Macias M; Fernández-Llébrez P; Rodríguez de Fonseca F
Biochem J; 2011 Jan; 433(1):175-85. PubMed ID: 20955176
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Ravinet Trillou C; Arnone M; Delgorge C; Gonalons N; Keane P; Maffrand JP; Soubrie P
Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R345-53. PubMed ID: 12399252
[TBL] [Abstract][Full Text] [Related]
7. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB
Yoshida K; Kita Y; Tokuoka SM; Hamano F; Yamazaki M; Sakimura K; Kano M; Shimizu T
FASEB J; 2019 Feb; 33(2):2484-2497. PubMed ID: 30265576
[TBL] [Abstract][Full Text] [Related]
8. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
[TBL] [Abstract][Full Text] [Related]
9. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet.
Wierucka-Rybak M; Wolak M; Bojanowska E
J Physiol Pharmacol; 2014 Aug; 65(4):487-96. PubMed ID: 25179081
[TBL] [Abstract][Full Text] [Related]
10. Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice.
Mathes CM; Ferrara M; Rowland NE
Pharmacol Biochem Behav; 2009 Nov; 94(1):119-23. PubMed ID: 19660493
[TBL] [Abstract][Full Text] [Related]
11. Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.
Tam J; Szanda G; Drori A; Liu Z; Cinar R; Kashiwaya Y; Reitman ML; Kunos G
Mol Metab; 2017 Oct; 6(10):1113-1125. PubMed ID: 29031713
[TBL] [Abstract][Full Text] [Related]
12. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
[TBL] [Abstract][Full Text] [Related]
13. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW
Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866
[TBL] [Abstract][Full Text] [Related]
14. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.
Rivera P; Romero-Zerbo Y; Pavón FJ; Serrano A; López-Ávalos MD; Cifuentes M; Grondona JM; Bermúdez-Silva FJ; Fernández-Llebrez P; de Fonseca FR; Suárez J; Pérez-Martín M
Eur J Neurosci; 2011 May; 33(9):1577-86. PubMed ID: 21395869
[TBL] [Abstract][Full Text] [Related]
15. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice.
Cardinal P; Bellocchio L; Clark S; Cannich A; Klugmann M; Lutz B; Marsicano G; Cota D
Endocrinology; 2012 Sep; 153(9):4136-43. PubMed ID: 22778221
[TBL] [Abstract][Full Text] [Related]
17. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
18. Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice.
Lazzari P; Sanna A; Mastinu A; Cabasino S; Manca I; Pani L
Behav Brain Res; 2011 Mar; 217(2):432-8. PubMed ID: 21074566
[TBL] [Abstract][Full Text] [Related]
19. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
Osei-Hyiaman D; Liu J; Zhou L; Godlewski G; Harvey-White J; Jeong WI; Bátkai S; Marsicano G; Lutz B; Buettner C; Kunos G
J Clin Invest; 2008 Sep; 118(9):3160-9. PubMed ID: 18677409
[TBL] [Abstract][Full Text] [Related]
20. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity.
Argueta DA; DiPatrizio NV
Physiol Behav; 2017 Mar; 171():32-39. PubMed ID: 28065722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
